Abstract
The ability to efficiently access cytosolic proteins is desired in both biological research and medicine. However, targeting intracellular proteins is often challenging, because to reach the cytosol, exogenous molecules must first traverse the cell membrane. This review provides a broad overview of how certain molecules are thought to cross this barrier, and what kinds of approaches are being made to enhance the intracellular delivery of those that are impermeable. We first discuss rules that govern the passive permeability of small molecules across the lipid membrane, and mechanisms of membrane transport that have evolved in nature for certain metabolites, peptides, and proteins. Then, we introduce design strategies that have emerged in the development of small molecules and peptides with improved permeability. Finally, intracellular delivery systems that have been engineered for protein payloads are surveyed. Viewpoints from varying disciplines have been brought together to provide a cohesive overview of how the membrane barrier is being overcome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Stein WD, Lieb WR (1986) Transport and diffusion across cell membranes, 1st edn. Academic, Orlando, FL
Alberts B, Johnson A, Lewis J et al (2007) Molecular biology of the cell, 5th edn. Garland Science, New York
Di L, Artursson P, Avdeef A et al (2012) Evidence-based approach to assess passive diffusion and carrier-mediated drug transport. Drug Discov Today 17:905–912. doi:10.1016/j.drudis.2012.03.015
Engelman DM (2005) Membranes are more mosaic than fluid. Nature 438:578–580. doi:10.1038/nature04394
Jacobson K, Mouritsen OG, Anderson RGW (2007) Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 9:7–14. doi:10.1038/ncb0107-7
Koichi K, Michiya F, Makoto N (1974) Lipid components of two different regions of an intestinal epithelial cell membrane of mouse. Biochim Biophys Acta 369:222–233. doi:10.1016/0005-2760(74)90253-7
Marsh D, Horváth LI (1998) Structure, dynamics and composition of the lipid-protein interface. Perspectives from spin-labelling. Biochim Biophys Acta 1376:267–296. doi:10.1016/S0304-4157(98)00009-4
Lee AG (2003) Lipid–protein interactions in biological membranes: a structural perspective. Biochim Biophys Acta 1612:1–40. doi:10.1016/S0005-2736(03)00056-7
Zachowski A (1993) Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 294:1–14
Leventis R, Silvius JR (2001) Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol. Biophys J 81:2257–2267. doi:10.1016/S0006-3495(01)75873-0
Steck TL, Ye J, Lange Y (2002) Probing red cell membrane cholesterol movement with cyclodextrin. Biophys J 83:2118–2125. doi:10.1016/S0006-3495(02)73972-6
Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422:37–44. doi:10.1038/nature01451
Mercer J, Helenius A (2009) Virus entry by macropinocytosis. Nat Cell Biol 11:510–520. doi:10.1038/ncb0509-510
Alberts B, Johnson A, Lewis J et al (2002) Molecular biology of the cell. http://www.ncbi.nlm.nih.gov/books/NBK21054/. Accessed 27 Feb 2014
Orsi M, Essex JW (2010) Passive permeation across lipid bilayers: a literature review. In: Molecular simulations and biomembranes: from biophysics to function, p 76–90
Kansy M, Senner F, Gubernator K (1998) Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 41:1007–1010. doi:10.1021/jm970530e
Sugano K, Kansy M, Artursson P et al (2010) Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov 9:597–614. doi:10.1038/nrd3187
Di L, Whitney-Pickett C, Umland JP et al (2011) Development of a new permeability assay using low-efflux MDCKII cells. J Pharm Sci 100:4974–4985. doi:10.1002/jps.22674
Shamu CE, Story CM, Rapoport TA, Ploegh HL (1999) The pathway of Us11-dependent degradation of Mhc class I heavy chains involves a ubiquitin-conjugated intermediate. J Cell Biol 147:45–58. doi:10.1083/jcb.147.1.45
Bartz R, Fan H, Zhang J et al (2011) Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. Biochem J 435:475–487. doi:10.1042/BJ20101021
Bittner MA, Holz RW (1988) Effects of tetanus toxin on catecholamine release from intact and digitonin-permeabilized chromaffin cells. J Neurochem 51:451–456. doi:10.1111/j.1471-4159.1988.tb01059.x
Moellering RE, Cornejo M, Davis TN et al (2009) Direct inhibition of the NOTCH transcription factor complex. Nature 462:182–188. doi:10.1038/nature08543
Chang YS, Graves B, Guerlavais V et al (2013) Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy. Proc Natl Acad Sci 110:E3445–E3454. doi:10.1073/pnas.1303002110
Bonner DK, Leung C, Chen-Liang J et al (2011) Intracellular trafficking of polyamidoamine-poly(ethylene glycol) block copolymers in DNA delivery. Bioconjug Chem 22:1519–1525. doi:10.1021/bc200059v
Richard JP, Melikov K, Vives E et al (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278:585–590. doi:10.1074/jbc.M209548200
Bechara C, Sagan S (2013) Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett 587:1693–1702. doi:10.1016/j.febslet.2013.04.031
Cebrian I, Visentin G, Blanchard N et al (2011) Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell 147:1355–1368. doi:10.1016/j.cell.2011.11.021
Yu P, Liu B, Kodadek T (2005) A high-throughput assay for assessing the cell permeability of combinatorial libraries. Nat Biotechnol 23:746–751. doi:10.1038/nbt1099
Holub JM, LaRochelle JR, Appelbaum JS, Schepartz A (2013) Improved assays for determining the cytosolic access of peptides, proteins, and their mimetics. Biochemistry (Mosc) 52:9036–9046. doi:10.1021/bi401069g
Zlokarnik G, Negulescu PA, Knapp TE et al (1998) Quantitation of transcription and clonal selection of single living cells with β-lactamase as reporter. Science 279:84–88. doi:10.1126/science.279.5347.84
Bordonaro M (2009) Modular Cre/lox system and genetic therapeutics for colorectal cancer. J Biomed Biotechnol. doi:10.1155/2009/358230
Yamaizumi M, Mekada E, Uchida T, Okada Y (1978) One molecule of diphtheria toxin fragment a introduced into a cell can kill the cell. Cell 15:245–250. doi:10.1016/0092-8674(78)90099-5
Eiklid K, Olsnes S, Pihl A (1980) Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp Cell Res 126:321–326. doi:10.1016/0014-4827(80)90270-0
Diamond JM, Katz Y (1974) Interpretation of nonelectrolyte partition coefficients between dimyristoyl lecithin and water. J Membr Biol 17:121–154. doi:10.1007/BF01870176
Finkelstein A (1976) Water and nonelectrolyte permeability of lipid bilayer membranes. J Gen Physiol 68:127–135. doi:10.1085/jgp.68.2.127
Subczynski WK, Hyde JS, Kusumi A (1989) Oxygen permeability of phosphatidylcholine–cholesterol membranes. Proc Natl Acad Sci 86:4474–4478
Gutknecht J, Bisson MA, Tosteson FC (1977) Diffusion of carbon dioxide through lipid bilayer membranes: effects of carbonic anhydrase, bicarbonate, and unstirred layers. J Gen Physiol 69:779–794. doi:10.1085/jgp.69.6.779
Walter A, Gutknecht J (1986) Permeability of small nonelectrolytes through lipid bilayer membranes. J Membr Biol 90:207–217. doi:10.1007/BF01870127
Orbach E, Finkelstein A (1980) The nonelectrolyte permeability of planar lipid bilayer membranes. J Gen Physiol 75:427–436. doi:10.1085/jgp.75.4.427
Papahadjopoulos D, Nir S, Oki S (1972) Permeability properties of phospholipid membranes: effect of cholesterol and temperature. Biochim Biophys Acta 266:561–583
Mendel CM (1989) The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 10:232–274. doi:10.1210/edrv-10-3-232
Giorgi EP, Stein WD (1981) The transport of steroids into animal cells in culture. Endocrinology 108:688–697. doi:10.1210/endo-108-2-688
Bockus AT, McEwen CM, Lokey RS (2013) Form and function in cyclic peptide natural products: a pharmacokinetic perspective. Curr Top Med Chem 13:821–836
Augustijns PF, Bradshaw TP, Gan LSL et al (1993) Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporine A transport. Biochem Biophys Res Commun 197:360–365. doi:10.1006/bbrc.1993.2487
Rezai T, Bock JE, Zhou MV et al (2006) Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. J Am Chem Soc 128:14073–14080. doi:10.1021/ja063076p
Guimarães CRW, Mathiowetz AM, Shalaeva M et al (2012) Use of 3D properties to characterize beyond rule-of-5 property space for passive permeation. J Chem Inf Model 52:882–890. doi:10.1021/ci300010y
Hediger MA, Clémençon B, Burrier RE, Bruford EA (2013) The ABCs of membrane transporters in health and disease (SLC series): introduction. Mol Aspects Med 34:95–107. doi:10.1016/j.mam.2012.12.009
Saier MH, Reddy VS, Tamang DG, Vastermark A (2013) The transporter classification database. Nucleic Acids Res 42:D251–D258. doi:10.1093/nar/gkt1097
Hediger MA (2013) The ABCs of membrane transporters in health and disease (SLC series). Mol Aspects Med 34(2–3):95–752
Kew JNC, Davies CH (2010) Ion channels: from structure to function. Oxford University Press, Oxford
Enyedi P, Czirják G (2010) Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol Rev 90:559–605. doi:10.1152/physrev.00029.2009
Toyoshima C, Kanai R, Cornelius F (2011) First crystal structures of Na+, K + -ATPase: new light on the oldest ion pump. Structure 19:1732–1738. doi:10.1016/j.str.2011.10.016
Duax WL, Griffin JF, Langs DA et al (1996) Molecular structure and mechanisms of action of cyclic and linear ion transport antibiotics. Pept Sci 40:141–155. doi:10.1002/(SICI)1097-0282(1996)40:1<141::AID-BIP6>3.0.CO;2-W
Wallace BA (1998) Recent advances in the high resolution structures of bacterial channels: gramicidin A. J Struct Biol 121:123–141. doi:10.1006/jsbi.1997.3948
Zheng L, Kostrewa D, Bernèche S et al (2004) The mechanism of ammonia transport based on the crystal structure of AmtB of Escherichia coli. Proc Natl Acad Sci U S A 101:17090–17095. doi:10.1073/pnas.0406475101
Andrade SLA, Einsle O (2007) The Amt/Mep/Rh family of ammonium transport proteins. Mol Membr Biol 24:357–365. doi:10.1080/09687680701388423
Shayakul C, Clémençon B, Hediger MA (2013) The urea transporter family (SLC14): physiological, pathological and structural aspects. Mol Aspects Med 34:313–322. doi:10.1016/j.mam.2012.12.003
Ishibashi K, Hara S, Kondo S (2009) Aquaporin water channels in mammals. Clin Exp Nephrol 13:107–117. doi:10.1007/s10157-008-0118-6
Bienert GP, Chaumont F (2013) Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide. Biochim Biophys Acta. doi:10.1016/j.bbagen.2013.09.017
Mueckler M, Thorens B (2013) The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 34:121–138. doi:10.1016/j.mam.2012.07.001
Schweikhard ES, Ziegler CM (2012) Amino acid secondary transporters: toward a common transport mechanism. Curr Top Membr 70:1–28. doi:10.1016/B978-0-12-394316-3.00001-6
Young JD, Yao SYM, Baldwin JM et al (2013) The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol Aspects Med 34:529–547. doi:10.1016/j.mam.2012.05.007
Smith DE, Clémençon B, Hediger MA (2013) Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Aspects Med 34:323–336. doi:10.1016/j.mam.2012.11.003
Letschert K, Faulstich H, Keller D, Keppler D (2006) Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci 91:140–149. doi:10.1093/toxsci/kfj141
Chen Z-S, Tiwari AK (2011) Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J 278:3226–3245. doi:10.1111/j.1742-4658.2011.08235.x
Amin ML (2013) P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights 7:27–34. doi:10.4137/DTI.S12519
Natarajan K, Xie Y, Baer MR, Ross DD (2012) Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol 83:1084–1103. doi:10.1016/j.bcp.2012.01.002
Langel U (2010) Handbook of cell-penetrating peptides, 2nd edn. CRC Press, Boca Raton
Sagan S, Burlina F, Alves ID et al (2013) Homeoproteins and homeoprotein-derived peptides: going in and out. Curr Pharm Des 19:2851–2862
Schmidt N, Mishra A, Lai GH, Wong GCL (2010) Arginine-rich cell-penetrating peptides. FEBS Lett 584:1806–1813. doi:10.1016/j.febslet.2009.11.046
Futaki S, Hirose H, Nakase I (2013) Arginine-rich peptides: methods of translocation through biological membranes. Curr Pharm Des 19:2863–2868
Tyagi M, Rusnati M, Presta M, Giacca M (2001) Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 276:3254–3261. doi:10.1074/jbc.M006701200
Su Y, Waring AJ, Ruchala P, Hong M (2010) Membrane-bound dynamic structure of an arginine-rich cell-penetrating peptide, the protein transduction domain of HIV TAT, from solid-state NMR. Biochemistry (Mosc) 49:6009–6020. doi:10.1021/bi100642n
Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10:310–315. doi:10.1038/nm996
Nakase I, Tadokoro A, Kawabata N et al (2007) Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry (Mosc) 46:492–501. doi:10.1021/bi0612824
Yesylevskyy S, Marrink S-J, Mark AE (2009) Alternative mechanisms for the interaction of the cell-penetrating peptides penetratin and the TAT peptide with lipid bilayers. Biophys J 97:40–49. doi:10.1016/j.bpj.2009.03.059
Herce HD, Garcia AE, Litt J et al (2009) Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophys J 97:1917–1925. doi:10.1016/j.bpj.2009.05.066
Mishra A, Lai GH, Schmidt NW et al (2011) Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions. Proc Natl Acad Sci 108:16883–16888. doi:10.1073/pnas.1108795108
Kawamoto S, Miyakawa T, Takasu M et al (2012) Cell-penetrating peptide induces various deformations of lipid bilayer membrane: inverted micelle, double bilayer, and transmembrane. Int J Quantum Chem 112:178–183. doi:10.1002/qua.23177
Huang K, García AE (2013) Free energy of translocating an arginine-rich cell-penetrating peptide across a lipid bilayer suggests pore formation. Biophys J 104:412–420. doi:10.1016/j.bpj.2012.10.027
Jones S, Howl J (2012) Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide. Bioconjug Chem 23:47–56. doi:10.1021/bc2002924
Tréhin R, Krauss U, Beck-Sickinger AG et al (2004) Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models. Pharm Res 21:1248–1256. doi:10.1023/B:PHAM.0000033013.45204.c3
Foerg C, Merkle HP (2008) On the biomedical promise of cell penetrating peptides: limits versus prospects. J Pharm Sci 97:144–162. doi:10.1002/jps.21117
Sandvig K, van Deurs B (2005) Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther 12:865–872. doi:10.1038/sj.gt.3302525
Falnes PØ, Sandvig K (2000) Penetration of protein toxins into cells. Curr Opin Cell Biol 12:407–413. doi:10.1016/S0955-0674(00)00109-5
Collier RJ (2009) Membrane translocation by anthrax toxin. Mol Aspects Med 30:413–422. doi:10.1016/j.mam.2009.06.003
De Virgilio M, Lombardi A, Caliandro R, Fabbrini MS (2010) Ribosome-inactivating proteins: from plant defense to tumor attack. Toxins 2:2699–2737. doi:10.3390/toxins2112699
Spooner RA, Lord JM (2012) How ricin and shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. In: Mantis N (ed) Ricin shiga toxins. Springer, Berlin, pp 19–40
Sandvig K, Skotland T, van Deurs B, Klokk TI (2013) Retrograde transport of protein toxins through the Golgi apparatus. Histochem Cell Biol 140:317–326. doi:10.1007/s00418-013-1111-z
Wernick NLB, Chinnapen DJ-F, Cho JA, Lencer WI (2010) Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum. Toxins 2:310–325. doi:10.3390/toxins2030310
Cho JA, Chinnapen DJ-F, Aamar E et al (2012) Insights on the trafficking and retro-translocation of glycosphingolipid-binding bacterial toxins. Front Cell Infect Microbiol. doi:10.3389/fcimb.2012.00051
Mercer J, Schelhaas M, Helenius A (2010) Virus entry by endocytosis. Annu Rev Biochem 79:803–833. doi:10.1146/annurev-biochem-060208-104626
Sriwilaijaroen N, Suzuki Y (2012) Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc Jpn Acad Ser B Phys Biol Sci 88:226–249. doi:10.2183/pjab.88.226
Tsai B (2007) Penetration of nonenveloped viruses into the cytoplasm. Annu Rev Cell Dev Biol 23:23–43. doi:10.1146/annurev.cellbio.23.090506.123454
Johnson J, Banerjee M (2008) Activation, exposure and penetration of virally encoded, membrane-active polypeptides during non-enveloped virus entry. Curr Protein Pept Sci 9:16–27. doi:10.2174/138920308783565732
Moyer CL, Nemerow GR (2011) Viral weapons of membrane destruction: variable modes of membrane penetration by non-enveloped viruses. Curr Opin Virol 1:44–99. doi:10.1016/j.coviro.2011.05.002
Inoue T, Tsai B (2013) How viruses use the endoplasmic reticulum for entry, replication, and assembly. Cold Spring Harb Perspect Biol 5:a013250. doi:10.1101/cshperspect.a013250
Suomalainen M, Greber UF (2013) Uncoating of non-enveloped viruses. Curr Opin Virol 3:27–33. doi:10.1016/j.coviro.2012.12.004
Veber DF, Johnson SR, Cheng H-Y et al (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615–2623. doi:10.1021/jm020017n
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–25. doi:10.1016/S0169-409X(96)00423-1
Faller B, Ottaviani G, Ertl P et al (2011) Evolution of the physicochemical properties of marketed drugs: can history foretell the future? Drug Discov Today 16:976–984. doi:10.1016/j.drudis.2011.07.003
Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714–3717. doi:10.1021/jm000942e
Xiang T-X, Anderson BD (1998) Influence of chain ordering on the selectivity of dipalmitoylphosphatidylcholine bilayer membranes for permeant size and shape. Biophys J 75:2658–2671. doi:10.1016/S0006-3495(98)77711-2
Kuhn B, Mohr P, Stahl M (2010) Intramolecular hydrogen bonding in medicinal chemistry. J Med Chem 53:2601–2611. doi:10.1021/jm100087s
Mayer PT, Xiang T-X, Anderson BD (2000) Independence of substituent contributions to the transport of small-molecule permeants in lipid bilayer. AAPS Pharm Sci 2:40–52. doi:10.1208/ps020214
Ulander J, Haymet ADJ (2003) Permeation across hydrated DPPC lipid bilayers: simulation of the titrable amphiphilic drug valproic acid. Biophys J 85:3475–3484. doi:10.1016/S0006-3495(03)74768-7
Xiang T-X, Anderson BD (2006) Liposomal drug transport: a molecular perspective from molecular dynamics simulations in lipid bilayers. Adv Drug Deliv Rev 58:1357–1378. doi:10.1016/j.addr.2006.09.002
Bennett WFD, MacCallum JL, Hinner MJ et al (2009) Molecular view of cholesterol flip-flop and chemical potential in different membrane environments. J Am Chem Soc 131:12714–12720. doi:10.1021/ja903529f
Maeda K, Sugiyama Y (2013) Transporter biology in drug approval: regulatory aspects. Mol Aspects Med 34:711–718. doi:10.1016/j.mam.2012.10.012
Dobson PD, Patel Y, Kell DB (2009) “Metabolite-likeness” as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov Today 14:31–40. doi:10.1016/j.drudis.2008.10.011
Dahan A, Khamis M, Agbaria R, Karaman R (2012) Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach. Expert Opin Drug Deliv 9:1001–1013. doi:10.1517/17425247.2012.697055
Majumdar S, Duvvuri S, Mitra AK (2004) Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development. Adv Drug Deliv Rev 56:1437–1452. doi:10.1016/j.addr.2004.02.006
Keppler A, Arrivoli C, Sironi L, Ellenberg J (2006) Fluorophores for live cell imaging of AGT fusion proteins across the visible spectrum. Biotechniques 41:167–170, 172, 174–175
Tsien RY (1981) A non-disruptive technique for loading calcium buffers and indicators into cells. Nature 290:527–528
Ries RS, Choi H, Blunck R et al (2004) Black lipid membranes: visualizing the structure, dynamics, and substrate dependence of membranes. J Phys Chem B 108:16040–16049. doi:10.1021/jp048098h
Melikyan GB, Deriy BN, Ok DC, Cohen FS (1996) Voltage-dependent translocation of R18 and DiI across lipid bilayers leads to fluorescence changes. Biophys J 71:2680–2691. doi:10.1016/S0006-3495(96)79459-6
Kleinfeld AM, Chu P, Storch J (1997) Flip-flop is slow and rate limiting for the movement of long chain anthroyloxy fatty acids across lipid vesicles. Biochemistry (Mosc) 36:5702–5711. doi:10.1021/bi962007s
Homolya L, Holló Z, Germann UA et al (1993) Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268:21493–21496
Chidley C, Haruki H, Pedersen MG et al (2011) A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis. Nat Chem Biol 7:375–383. doi:10.1038/nchembio.557
Driggers EM, Hale SP, Lee J, Terrett NK (2008) The exploration of macrocycles for drug discovery—an underexploited structural class. Nat Rev Drug Discov 7:608–624. doi:10.1038/nrd2590
Giordanetto F, Revell JD, Knerr L et al (2013) Stapled vasoactive intestinal peptide (VIP) derivatives improve VPAC2 agonism and glucose-dependent insulin secretion. ACS Med Chem Lett 4:1163–1168. doi:10.1021/ml400257h
Bock JE, Gavenonis J, Kritzer JA (2013) Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints. ACS Chem Biol 8:488–499. doi:10.1021/cb300515u
Kwon Y-U, Kodadek T (2007) Quantitative comparison of the relative cell permeability of cyclic and linear peptides. Chem Biol 14:671–677. doi:10.1016/j.chembiol.2007.05.006
White TR, Renzelman CM, Rand AC et al (2011) On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds. Nat Chem Biol 7:810–817. doi:10.1038/nchembio.664
Malakoutikhah M, Prades R, Teixidó M, Giralt E (2010) N-methyl phenylalanine-rich peptides as highly versatile blood−brain barrier shuttles. J Med Chem 53:2354–2363. doi:10.1021/jm901654x
Ovadia O, Greenberg S, Chatterjee J et al (2011) The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides. Mol Pharm 8:479–487. doi:10.1021/mp1003306
Azzarito V, Long K, Murphy NS, Wilson AJ (2013) Inhibition of α-helix-mediated protein–protein interactions using designed molecules. Nat Chem 5:161–173. doi:10.1038/nchem.1568
Kim Y-W, Grossmann TN, Verdine GL (2011) Synthesis of all-hydrocarbon stapled α-helical peptides by ring-closing olefin metathesis. Nat Protoc 6:761–771. doi:10.1038/nprot.2011.324
Patgiri A, Menzenski MZ, Mahon AB, Arora PS (2010) Solid-phase synthesis of short α-helices stabilized by the hydrogen bond surrogate approach. Nat Protoc 5:1857–1865. doi:10.1038/nprot.2010.146
Miller SE, Kallenbach NR, Arora PS (2012) Reversible alpha-helix formation controlled by a hydrogen bond surrogate. Tetrahedron 68:4434–4437. doi:10.1016/j.tet.2011.12.068
Patgiri A, Yadav KK, Arora PS, Bar-Sagi D (2011) An orthosteric inhibitor of the Ras-Sos interaction. Nat Chem Biol 7:585–587. doi:10.1038/nchembio.612
Okamoto T, Zobel K, Fedorova A et al (2013) Stabilizing the pro-apoptotic BimBH3 Helix (BimSAHB) does not necessarily enhance affinity or biological activity. ACS Chem Biol 8:297–302. doi:10.1021/cb3005403
Bird GH, Gavathiotis E, LaBelle JL et al (2014) Distinct BimBH3 (BimSAHB) stapled peptides for structural and cellular studies. ACS Chem Biol 9:831–837. doi:10.1021/cb4003305
Okamoto T, Segal D, Zobel K et al (2014) Further insights into the effects of pre-organizing the BimBH3 helix. ACS Chem Biol 9:838–839. doi:10.1021/cb400638p
Verdine GL, Hilinski GJ (2012) Stapled peptides for intracellular drug targets. In: Dane Wittrup K, Verdine GL (eds) Methods enzymol. Academic, New York, pp 3–33
Bird GH, Christian Crannell W, Walensky LD (2011) Chemical synthesis of hydrocarbon-stapled peptides for protein interaction research and therapeutic targeting. Curr Protoc Chem Biol 3(3):99–117
Milletti F (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 17:850–860. doi:10.1016/j.drudis.2012.03.002
Copolovici DM, Langel K, Eriste E, Langel U (2014) Cell-penetrating peptides: design synthesis and applications. ACS Nano. doi:10.1021/nn4057269
Appelbaum JS, LaRochelle JR, Smith BA et al (2012) Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm. Chem Biol 19:819–830. doi:10.1016/j.chembiol.2012.05.022
Marschall ALJ, Frenzel A, Schirrmann T et al (2011) Targeting antibodies to the cytoplasm. mAbs 3:3–16. doi:10.4161/mabs.3.1.14110
Gu Z, Biswas A, Zhao M, Tang Y (2011) Tailoring nanocarriers for intracellular protein delivery. Chem Soc Rev 40:3638–3655. doi:10.1039/C0CS00227E
Du J, Jin J, Yan M, Lu Y (2012) Synthetic nanocarriers for intracellular protein delivery. Curr Drug Metab 13:82–92. doi:10.2174/138920012798356862
Salmaso S, Caliceti P (2013) Self assembling nanocomposites for protein delivery: supramolecular interactions of soluble polymers with protein drugs. Int J Pharm 440:111–123. doi:10.1016/j.ijpharm.2011.12.029
Zhang Y, Yu L-C (2008) Microinjection as a tool of mechanical delivery. Curr Opin Biotechnol 19:506–510. doi:10.1016/j.copbio.2008.07.005
Sharei A, Zoldan J, Adamo A et al (2013) A vector-free microfluidic platform for intracellular delivery. Proc Natl Acad Sci 110:2082–2087. doi:10.1073/pnas.1218705110
Shalek AK, Robinson JT, Karp ES et al (2010) Vertical silicon nanowires as a universal platform for delivering biomolecules into living cells. Proc Natl Acad Sci 107:1870–1875. doi:10.1073/pnas.0909350107
Yosef N, Shalek AK, Gaublomme JT et al (2013) Dynamic regulatory network controlling TH17 cell differentiation. Nature 496:461–468. doi:10.1038/nature11981
Lo SL, Wang S (2010) Peptide-based nanocarriers for intracellular delivery of biologically active proteins. In: Organelle-specific pharmaceutical nanotechnology, p 323–336
Koren E, Torchilin VP (2012) Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 18:385–393. doi:10.1016/j.molmed.2012.04.012
Nakase I, Tanaka G, Futaki S (2013) Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells. Mol Biosyst 9:855–861. doi:10.1039/C2MB25467K
Fawell S, Seery J, Daikh Y et al (1994) Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci 91:664–668. doi:10.1073/pnas.91.2.664
Nagahara H, Vocero-Akbani AM, Snyder EL et al (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4:1449–1452. doi:10.1038/4042
Morris MC, Depollier J, Mery J et al (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19:1173–1176. doi:10.1038/nbt1201-1173
Harford-Wright E, Lewis KM, Vink R, Ghabriel MN (2014) Evaluating the role of substance P in the growth of brain tumors. Neuroscience 261:85–94. doi:10.1016/j.neuroscience.2013.12.027
Rizk SS, Luchniak A, Uysal S et al (2009) An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells. Proc Natl Acad Sci 106:11011–11015. doi:10.1073/pnas.0904907106
Rizk SS, Misiura A, Paduch M, Kossiakoff AA (2011) Substance P derivatives as versatile tools for specific delivery of various types of biomolecular cargo. Bioconjug Chem 23:42–46. doi:10.1021/bc200496e
Chatterjee S, Chaudhury S, McShan AC et al (2013) Structure and biophysics of type III secretion in bacteria. Biochemistry (Mosc) 52:2508–2517. doi:10.1021/bi400160a
Carleton HA, Lara-Tejero M, Liu X, Galán JE (2013) Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery. Nat Commun 4:1590. doi:10.1038/ncomms2594
Doerner JF, Febvay S, Clapham DE (2012) Controlled delivery of bioactive molecules into live cells using the bacterial mechanosensitive channel MscL. Nat Commun 3:990. doi:10.1038/ncomms1999
Dunstone MA, Tweten RK (2012) Packing a punch: the mechanism of pore formation by cholesterol dependent cytolysins and membrane attack complex/perforin-like proteins. Curr Opin Struct Biol 22:342–349. doi:10.1016/j.sbi.2012.04.008
Provoda CJ, Stier EM, Lee K-D (2003) Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin. J Biol Chem 278:35102–35108. doi:10.1074/jbc.M305411200
Pirie CM, Liu DV, Wittrup KD (2013) Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin. Mol Cancer Ther 12:1774–1782. doi:10.1158/1535-7163.MCT-12-1023
Sandvig K, van Deurs B (2002) Membrane traffic exploited by protein toxins. Annu Rev Cell Dev Biol 18:1–24. doi:10.1146/annurev.cellbio.18.011502.142107
Johannes L, Römer W (2010) Shiga toxins—from cell biology to biomedical applications. Nat Rev Microbiol 8:105–116. doi:10.1038/nrmicro2279
Pastan I, Hassan R, FitzGerald DJ, Kreitman RJ (2007) Immunotoxin treatment of cancer. Annu Rev Med 58:221–237. doi:10.1146/annurev.med.58.070605.115320
FitzGerald DJ, Wayne AS, Kreitman RJ, Pastan I (2011) Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates. Cancer Res 71:6300–6309. doi:10.1158/0008-5472.CAN-11-1374
Lawrence MS, Phillips KJ, Liu DR (2007) Supercharging proteins can impart unusual resilience. J Am Chem Soc 129:10110–10112. doi:10.1021/ja071641y
Cronican JJ, Thompson DB, Beier KT et al (2010) Potent delivery of functional proteins into mammalian cells in vitro and in vivo using a supercharged protein. ACS Chem Biol 5:747–752. doi:10.1021/cb1001153
Cronican JJ, Beier KT, Davis TN et al (2011) A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo. Chem Biol 18:833–838. doi:10.1016/j.chembiol.2011.07.003
Weisbart RH, Noritake DT, Wong AL et al (1990) A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus. J Immunol 144:2653–2658
Hansen JE, Chan G, Liu Y et al (2012) Targeting cancer with a lupus autoantibody. Sci Transl Med 4:157ra142. doi:10.1126/scitranslmed.3004385
Lawlor MW, Armstrong D, Viola MG et al (2013) Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. Hum Mol Genet 22:1525–1538. doi:10.1093/hmg/ddt003
Kaczmarczyk SJ, Sitaraman K, Young HA et al (2011) Protein delivery using engineered virus-like particles. Proc Natl Acad Sci 108:16998–17003. doi:10.1073/pnas.1101874108
Tao P, Mahalingam M, Marasa BS et al (2013) In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine. Proc Natl Acad Sci 110:5846–5851. doi:10.1073/pnas.1300867110
Mallery DL, McEwan WA, Bidgood SR et al (2010) Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci 107:19985–19990. doi:10.1073/pnas.1014074107
Torchilin V (2008) Intracellular delivery of protein and peptide therapeutics. Drug Discov Today Technol 5:e95–e103. doi:10.1016/j.ddtec.2009.01.002
Zelphati O, Wang Y, Kitada S et al (2001) Intracellular delivery of proteins with a new lipid-mediated delivery system. J Biol Chem 276:35103–35110. doi:10.1074/jbc.M104920200
Benjaminsen RV, Mattebjerg MA, Henriksen JR et al (2013) The possible “proton sponge” effect of polyethylenimine (PEI) does not include change in lysosomal pH. Mol Ther 21:149–157. doi:10.1038/mt.2012.185
Behr J-P (1997) The proton sponge: a trick to enter cells the viruses did not exploit. Chim Int J Chem 51:34–36
Lynn DM, Langer R (2000) Degradable poly(β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 122:10761–10768. doi:10.1021/ja0015388
Su X, Yang N, Wittrup KD, Irvine DJ (2013) Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticles. Biomacromolecules 14:1093–1102. doi:10.1021/bm3019906
Gu Z, Yan M, Hu B et al (2009) Protein nanocapsule weaved with enzymatically degradable polymeric network. Nano Lett 9:4533–4538. doi:10.1021/nl902935b
Yan M, Du J, Gu Z et al (2010) A novel intracellular protein delivery platform based on single-protein nanocapsules. Nat Nanotechnol 5:48–53. doi:10.1038/nnano.2009.341
Biswas A, Joo K-I, Liu J et al (2011) Endoprotease-mediated intracellular protein delivery using nanocapsules. ACS Nano 5:1385–1394. doi:10.1021/nn1031005
Malmsten M (2013) Inorganic nanomaterials as delivery systems for proteins, peptides, DNA, and siRNA. Curr Opin Colloid Interface Sci 18:468–480. doi:10.1016/j.cocis.2013.06.002
Loosli H-R, Kessler H, Oschkinat H et al (1985) Peptide conformations. Part 31. The conformation of cyclosporin a in the crystal and in solution. Helv Chim Acta 68:682–704. doi:10.1002/hlca.19850680319
Bayer P, Kraft M, Ejchart A et al (1995) Structural studies of HIV-1 tat protein. J Mol Biol 247:529–535. doi:10.1016/S0022-2836(05)80133-0
Feld GK, Thoren KL, Kintzer AF et al (2010) Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers. Nat Struct Mol Biol 17:1383–1390. doi:10.1038/nsmb.1923
Varghese Gupta S, Gupta D, Sun J et al (2011) Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach. Mol Pharm 8:2358–2367. doi:10.1021/mp200291x
Acknowledgements
The authors thank Bradley Pentelute, Alessandro Angelini, Sandrine Sagan, Alexander H. de Vries, and Christopher Chidley for helpful discussions and critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Yang, N.J., Hinner, M.J. (2015). Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins. In: Gautier, A., Hinner, M. (eds) Site-Specific Protein Labeling. Methods in Molecular Biology, vol 1266. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2272-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2272-7_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2271-0
Online ISBN: 978-1-4939-2272-7
eBook Packages: Springer Protocols